GABAergic and Glutamatergic Deficits in Schizophrenia: Pathophysiological Mechanisms Underlying Negative Symptoms and Cognitive Impairment

Schizophrenia is a complex neurodevelopmental disorder characterized by positive, negative, and cognitive symptoms. While classical dopaminergic models explain psychotic features, they fail to address the debilitating negative and cognitive deficits that dictate long-term disability. We aim to synthesize contemporary evidence on the impairment of the excitatory/inhibitory (E/I) balance within cortical microcircuits as a central pathophysiological hypothesis of the disorder. The cascade is hypothesized to be driven by N-methyl-D-aspartate (NMDA) receptor hypofunction, which impairs parvalbumin-positive (PV+) interneurons and consequently downregulates glutamic acid decarboxylase (GAD67)-mediated gamma-aminobutyric acid (GABA) synthesis. Weakened PV+ interneuron function disrupts Pyramidal-Interneuron Network Gamma (PING) dynamics, reducing gamma-band synchronization and fronto-temporo-thalamic connectivity. At the macroscopic and cellular levels, the E/I imbalance is linked to reduced neuropil volume and aberrant synaptic pruning that disturbs dendritic architecture. Clinically, this triggers severe working memory dysfunction, cognitive rigidity, avolition, and anhedonia. This paper presents emerging glutamatergic and GABAergic pharmacological strategies, including glycine, D-serine, and metabotropic glutamate receptor (mGluR) modulators. We highlight key directions for future research, emphasizing the use of translational biomarkers (e.g., mismatch negativity (MMN), magnetic resonance spectroscopy (MRS), and gamma oscillations) to normalize PV+ interneuron function and network-level synchronization.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-17
DOI
https://doi.org/10.3390/ijms272210293
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GABAergic and Glutamatergic Deficits in Schizophrenia: Pathophysiological Mechanisms Underlying Negative Symptoms and Cognitive Impairment

Agata Gabryelska, Dominik Strzelecki, Anna Maria Zakrzewska
International Journal of Molecular Sciences
Schizophrenia research and treatment
article

GABAergic and Glutamatergic Deficits in Schizophrenia: Pathophysiological Mechanisms Underlying Negative Symptoms and Cognitive Impairment

Agata Gabryelska, Dominik Strzelecki, Anna Maria Zakrzewska
article en

Abstract

Schizophrenia is a complex neurodevelopmental disorder characterized by positive, negative, and cognitive symptoms. While classical dopaminergic models explain psychotic features, they fail to address the debilitating negative and cognitive deficits that dictate long-term disability. We aim to synthesize contemporary evidence on the impairment of the excitatory/inhibitory (E/I) balance within cortical microcircuits as a central pathophysiological hypothesis of the disorder. The cascade is hypothesized to be driven by N-methyl-D-aspartate (NMDA) receptor hypofunction, which impairs parvalbumin-positive (PV+) interneurons and consequently downregulates glutamic acid decarboxylase (GAD67)-mediated gamma-aminobutyric acid (GABA) synthesis. Weakened PV+ interneuron function disrupts Pyramidal-Interneuron Network Gamma (PING) dynamics, reducing gamma-band synchronization and fronto-temporo-thalamic connectivity. At the macroscopic and cellular levels, the E/I imbalance is linked to reduced neuropil volume and aberrant synaptic pruning that disturbs dendritic architecture. Clinically, this triggers severe working memory dysfunction, cognitive rigidity, avolition, and anhedonia. This paper presents emerging glutamatergic and GABAergic pharmacological strategies, including glycine, D-serine, and metabotropic glutamate receptor (mGluR) modulators. We highlight key directions for future research, emphasizing the use of translational biomarkers (e.g., mismatch negativity (MMN), magnetic resonance spectroscopy (MRS), and gamma oscillations) to normalize PV+ interneuron function and network-level synchronization.

International Journal of Molecular SciencesVol. 27(22)
Medical University of Lodz (PL)
Good health and well-being
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon